3. Ralston K.S., Petri WA Jr. Tissue destruction and invasion by Entamoeba histolytica.
4. Tanyuksel M., Petri W.A. Jr. Laboratory diagnosis of amebiasis.
5. Maltz G., Knauer C.M. Amebic liver abscess: a 15-year experience.
6. [Guideline] World Health Organization. Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups.
7. Dold C., Holland C.V. Ascaris and ascariasis.
8. Gangopadhyay A.N., Upadhyaya V.D., Gupta D.K. et al. Conservative treatment for round worm intestinal obstruction.
9. Das A.K. Hepatic and biliary ascariasis.
10. Wani I. Gallbladder ascariasis.
11. [Guideline] Brunetti E., Kern P., Vuitton D.A, Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans.
12. Macpherson C.N., Bartholomot B., Frider B. Application of ultrasound in diagnosis, treatment, epidemiology, public health and control of Echinococcus granulosus and E. multilocularis.
13. Junghanss T., da Silva A.M., Horton J., Chiodini P.L., Brunetti E. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives.
14. McManus D.P., Zhang W., Li J., Bartley P.B. Echinococcosis.
15. Filippou D, Tselepis D, Filippou G, Papadopoulos V. Advances in liver echinococcosis: diagnosis and treatment.
16. Parija S.C. Textbook of Medical Parasitology.
17. Sakru N., Korkmaz M., Demirci M., Kuman A. Ok U.Z. Fasciola hepatica infection in echinococcosis suspected cases.
18. Garcia L.S.
19. Ubeira F.M., Muino L., Valero M.A., Periago M.V., Perez-Crespo I., Mezo M. MM3-ELISA detection of Fasciola hepatica coproantigens in preserved human stool samples.
20. Ezzat R.F., Karboli T.A., Kasnazani K.A., Hamawandi A.M.. Endoscopic management of biliary fascioliasis: a case report.
1. Fleming R.E., Britton R.S., Waheed A. et al. Pathogenesis of hereditary hemochromatosis.
2. Adams P.C., Barton J.C. Haemochromatosis.
3. Gattermann N. The treatment of secondary hemochromatosis.
4. Parkkila S., Niemela O., Britton R.S. et al. Molecular aspects of iron absorption and HFE expression.
5. Allen K.J., Gurrin L.C., Constantine C.C. et al. Iron-overload-related disease in HFE hereditary hemochromatosis.
6. Janssen M.C., Swinkels D.W. Hereditary haemochromatosis.
7. Gurrin L.C., Bertalli N.A., Dalton G.W. et al. HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity.
8. Brissot P. Optimizing the diagnosis and the treatment of iron overload diseases.
9. Dusek P., Roos P.M., Litwin T., Schneider S.A., Flaten T.P., Aaseth J. The neurotoxicity of iron, copper and manganese in Parkinson’s and Wilson’s diseases.
10. Rodriguez-Castro K.I., Hevia-Urrutia F.J., Sturniolo G.C. Wilson’s disease: A review of what we have learned.
11. Schilsky M.L. Wilson disease: diagnosis, treatment, and follow-up.
12. Roberts E.A., Schilsky M.L. American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update.